A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers

BACKGROUND: There is increasing interest in the use of purified cannabidiol (CBD) as a treatment for a wide range of conditions due to its reported anti-inflammatory, anxiolytic, antiemetic and anticonvulsant properties. OBJECTIVE: The objective of this study was to assess the safety, tolerability a...

Descripción completa

Detalles Bibliográficos
Autores principales: Perkins, Daniel, Butler, Juliet, Ong, Katherine, Nguyen, Tri-Hung, Cox, Susan, Francis, Barbara, Mcintosh, Michelle, Lilley, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511474/
https://www.ncbi.nlm.nih.gov/pubmed/32409982
http://dx.doi.org/10.1007/s13318-020-00624-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511474/
https://www.ncbi.nlm.nih.gov/pubmed/32409982
http://dx.doi.org/10.1007/s13318-020-00624-6

Ejemplares similares